NBIA Symposium 2020 takes place online

NBIA Symposium 2020 takes place online

 The 7th International Symposium on NBIA and Related Disorders will now take place virtually from September 30 to October 3, 2020.
Save the date for our virtual symposium!

- Update on new findings in NBIA diseases -
- Progress in therapies for NBIA -
- Round table discussions -

An agenda, a dedicated website and registration will be available shortly.

Scientific Steering Committee:

Prof. Dr. Thomas Klopstock - LMU Munich - Germany
Dr. Susan Hayflick - OHSU Portland - USA
Dr. Valeria Tiranti - Neurological Institute Carlo Besta Milan - Italy
Dr. Agnès Rotig - Institut Imagine Paris - France
Fatemeh Mollet - NBIA Suisse - Switzerland
Angelika Klucken - Hoffnungsbaum e.V. - Germany
Patricia Wood - NBIA Disorders Association - USA

If you have any queries or require further information, please contact Angelika Klucken at info@hoffnungsbaum.de or (in English please) contact Patricia Wood at pwood@NBIAdisorders.org.
English information is available on the website of the NBIA Disorders Association: https://www.nbiadisorders.org/research/research-meetings/356-intl-symposium-2020

 

7th International NBIA Symposium in Lausanne postponed!

7th International NBIA Symposium in Lausanne postponed!

Postponed to fall 2021 due to the corona situation

Unfortunately, the 7th International NBIA Symposium will not take place from October 1-3, 2020 in Lausanne, Switzerland, and will be postponed to fall 2021. For three days, scientists and physicians from all over the world will be invited to share their work and develop new strategies. Learn about the latest NBIA research. Share your experiences in the treatment of NBIA and take part in discussions.

NBIA-Suisse is in charge of the organization together with the Friedrich Baur Institute. As soon as a new date has been set, we will announce it here.

Contact us
Fatemeh Mollet
nbiasuisse@gmail.com
www.nbiasuisse.org

Source: NBIA-Suisse

Charity campaign "Together strong for Maya" for MPAN research

Charity campaign "Together strong for Maya" for MPAN research

A large charity event was held in Lauterbach on June 1, 2019. The fate of 12-year-old Maya, who is suffering from the NBIA variant MPAN, moves the whole town, many other people in Saarland and beyond. They all want to help Maya and her fellow sufferers with MPAN and so many donations have already been collected. Of course, the best help is an effective therapy that stops the severe course of the disease. But such a therapy does not yet exist. This requires extensive and time-consuming further research.

This is because there are major research deficits at MPAN because too few researchers worldwide are working on it, the financial resources for the implementation of sustainable, promising MPAN projects have not yet been sufficient and, in particular, essential findings from basic research are still missing to achieve a breakthrough.
Stephanie Matthiesen, Maya's mother, reports in moving words about the great willingness of the people in her region to help: "Edeltraud Closen from Gasthaus zum Warndt did not know our Maya personally at first. And yet, with the great support of the comrades of the Lauterbach volunteer fire brigade, she and her team have put together a charity festival for Maya within just under 2 months, which is second to none: including road closure, huge raffle with great prizes from fantastic sponsors and great performances throughout the day. Food and drink were well taken care of and the children were able to let off steam on the bouncy castle and on a fire ladder as well as stacking boxes. An unbelievable number of people were there and everyone helped with all their commitment and celebrated exuberantly. Every hug, every kind word and every smile has done us good. We are very grateful for that."

"The proceeds of the event are total madness," she adds. "More than 19,000 euros have been raised for research through this festival. With this amount from the festival and the money we continue to generate, we have been able to reach the incredible donation amount of more than 120,000 euros so far. This fills us with hope that MPAN research will receive a boost and a lasting boost as a result. We would like to thank all our donors."

Hoffnungsbaum e.V. makes every effort to ensure that the funds now available for MPAN research are used for quality-tested research projects as soon as possible. Projects are needed that can elucidate the underlying disease mechanisms in MPAN, identify potential treatment options or test the efficacy and safety of new therapeutic approaches in clinical trials. The money collected in the fundraiser will make a substantial contribution to this.

MPAN can also be inherited in an autosomal dominant manner

MPAN can also be inherited in an autosomal dominant manner

The NBIA research group of Dr. Susan Hayflick at Oregon Health & Science University in Portland (OR, USA) has discovered that mitochondrial membrane protein-associated neurodegeneration (MPAN) can also be inherited in an autosomal dominant manner. MPAN is one of the four most common NBIA variants and is caused by mutations in the gene C19orf12. Until now, it was assumed that the disease is inherited exclusively in an autosomal recessive manner. This means that there must be 2 mutations to trigger the disease, one each from the father and the mother. In a new publication, however, Hayflick and her team show that there are also a number of MPAN patients in whom a mutation alone can trigger the disease with the symptoms typical of MPAN. It was also possible to detect isolated mutations that were not inherited but had new occurrences in the patients, so-called de novo mutations.

Implications for diagnostics and genetic counseling

These research findings have implications for the diagnosis and genetic counseling of MPAN patients and their families. If a single MPAN mutation is detected in a patient with clinical symptoms of MPAN, the treating physician must consider autosomal dominant MPAN in the differential diagnosis. According to the authors of the article, the respective genotype can often provide information about whether a single mutation is sufficient to trigger the disease. Since MPAN can only occur in adulthood, the latest findings are of considerable importance for those affected by dominant MPAN. Your children are at increased risk of developing the disease as well.

 

Bibliographic information for the article:
Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J,
Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, Garcia D, Krajbich V, Pham T, Woltjer R, George BP, Minks KQ, Paciorkowski AR, Hogarth P, Jankovic J, Hayflick SJ. Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). Mol Genet Genomic Med. 2019 May 13;:e736.

Here is the link to the Pubmed abstract:
https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&dopt=Abstract&db=PubMed&list_uids=31087512 

Here is the link to the full article:
https://onlinelibrary.wiley.com/doi/full/10.1002/mgg3.736

Call for proposals for the funding of NBIA research projects

Call for proposals for the funding of NBIA research projects

The NBIA patient organizations AISNAF (Italy), Hoffnungsbaum e.V.(Germany) and NBIA Disorders Association (USA) announce a joint funding initiative to award research grants for the study of the following two NBIA variants:

  1. Beta-propeller protein associated neurodegeneration (BPAN - gene WDR45):
    Funding of up to €65,000 is available for an 18-month research project on BPAN.
  2. Mitochondrial membrane protein-associated neurodegeneration (MPAN gene c19orf12):
    Funding of up to € 90,000 is available for a 2-year research project on MPAN.  

Deadline for the submission of proposals: May 13, 2019

As manager of this international joint initiative, the Italian patient organization AISNAF is currently accepting applications with project proposals. The research projects are intended to pave the way for new treatment options for the aforementioned NBIA diseases.

Further information and the funding application can be found here:
https://www.aisnaf.org/bandi-per-progetti-calls-for-proposals/

The participation of Hoffnungsbaum e.V. in this funding initiative was made possible by the "Milly's Mission" fundraising campaigns of the Nielbock family (www.millys-mission.de) and "Help Maya" https://helft-maya.de/ from the Matthiesen family.
On behalf of all those affected by BPAN and MPAN, we would like to thank the two families and all donors for their commitment, which Hoffnungsbaum e.V. which has enabled us to provide a total of €46,000 for BPAN and MPAN research projects.

Subscribe to our Hoffnungsbaum newsletter!

With our newsletter e-mails you will receive valuable information about NBIA. If you would like to receive additional information on individual NBIA variants or special information for researchers/clinicians in addition to the general newsletter, please click here: Subscribe to additional information

Privacy policy

You have successfully registered!